Howard Morgan ’84 became chair of the Parkinson’s Foundation board of directors in June. He’d been involved with a previous iteration of the board since 2004, drawn to the cause because his late father suffered from the disease. Morgan sees opportunity and obligation in taking on the role.
The foundation was born two years ago from a merger of the Parkinson’s Disease Foundation, of which Morgan was a part, and the National Parkinson’s Foundation. “It was a chance to use my merger and acquisition skill set, my private equity skill set, to combine two not-for-profits — really a kind of a merger of equals,” he says. “The opportunity, almost the obligation, to try to make that happen was once-in-a-lifetime.”
Morgan is a partner and the senior -managing director of Argand Partners, and the foundation saw him as a leader who could accelerate its growth. It’s a chance, he says, to have an impact on people with Parkinson’s, “both trying to cure it — maybe that’s too aspirational — but certainly making lives better for those who have it, and, just as important, for those who care for those who have it.”
